|
1
|
Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
|
Chest
|
2005
|
4.29
|
|
2
|
Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.
|
J Aerosol Med Pulm Drug Deliv
|
2010
|
1.08
|
|
3
|
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis.
|
Pediatr Pulmonol
|
2002
|
0.94
|
|
4
|
Standardization of the single-breath diffusing capacity in a multicenter clinical trial.
|
Chest
|
2007
|
0.88
|
|
5
|
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.
|
J Allergy Clin Immunol
|
2002
|
0.87
|
|
6
|
Tobramycin as a pharmacologic tracer to compare airway deposition from nebulizers.
|
Pharmacotherapy
|
2002
|
0.84
|
|
7
|
Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.
|
Am J Respir Crit Care Med
|
2008
|
0.75
|
|
8
|
Long-term intersession variability for single-breath diffusing capacity.
|
Respiration
|
2011
|
0.75
|